Belgium-based IntelliProve, a healthtech company specializing in digital healthcare solutions, has raised €1.25M in seed funding to further its innovative approach to preventive healthcare. By leveraging contactless optical facial scans, the company provides real-time health insights aimed at improving accessibility and inclusivity in health monitoring. The funding is expected to amplify its European reach and refine its technology to meet growing healthcare demands, especially in corporate wellbeing and insurance sectors.
Previously, IntelliProve had already established itself as a key player in the digital health field by forming partnerships with organizations like Het Wit-Gele Kruis and TU Delft. Its CE-marked and ISO27001-certified product is integrated into diverse platforms, enabling digital health solutions to scale rapidly. In 2024, IntelliProve significantly increased its revenue and expanded to seven European countries, demonstrating its scalability and market acceptance compared to earlier years when its platform had a more limited scope.
What differentiates IntelliProve from traditional health checks?
IntelliProve replaces conventional methods of health assessment, such as wearable devices and manual questionnaires, with a contactless software solution powered by computer vision and signal processing. This smartphone-based platform conducts what the company terms “digital biopsies,” offering preventative healthcare insights without the need for physical contact. The product has been designed to integrate seamlessly into existing ecosystems, from digital health applications to corporate wellness programs.
Who is supporting this initiative?
The funding round attracted a diverse group of investors, including Miles Ahead, The White and Yellow Cross, imec.istart, and prominent tech entrepreneurs such as Jeroen De Wit (Teamleader) and Louis Jonckheere (Showpad). Key backers cited the company’s potential for scaling and its alignment with the growing demand for personalized healthcare solutions. According to IntelliProve co-founder Joeri Tulkens, the support from both research-oriented and business-savvy investors positions the company for accelerated growth.
“We have a great product, a fantastic team, and supportive research partners,” said Tulkens. “This funding comes at the perfect time to help us scale further.”
IntelliProve reported a notable increase in software usage over the last two years and aims to perform 10 billion health evaluations by 2028. Its ambitious plans also extend to doubling its workforce within a year to support technological advancements and market expansion. Operating from the Wintercircus in Ghent, the current eight-member team combines expertise across technology, healthcare, and business to drive innovation in digital healthcare.
Investors such as Miles Ahead and imec.istart bring extensive expertise in supporting early-stage startups and scaling deep-tech platforms. Miles Ahead manages €30M in capital and focuses on AI and deep-tech ventures. Imec.istart has been instrumental in accelerating over 300 tech startups since 2011, offering both financial and strategic resources. Meanwhile, The White and Yellow Cross, a prominent healthcare organization in Belgium, underlines its commitment to IntelliProve’s preventive healthcare focus.
The funding reflects a broader trend of increasing investment in healthtech solutions that address contemporary healthcare challenges. IntelliProve’s approach of integrating advanced technology into health assessments is positioned to capture the interest of stakeholders in both public and private healthcare sectors. By eliminating the need for specialized equipment, the company’s platform reduces costs and broadens accessibility, addressing critical gaps in modern healthcare systems.
